USX:BIO - Bio-Rad Laboratories Inc. (USD 393.14) Bio-Rad Laboratories Inc.
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   


Yahoo Finance

USD 393.14    -9.920 (-2.46%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


Overview

9 Apr 2020

Day Change: -9.920 (-2.46%)

52 Wk Range: 281.66 - 413.02

Day's Range: 392.59 - 408.7

Last Volume: 282,189

Current Yield: 0%

Projected Yield: 0%

Open: USD 405.37

9 Apr 2020

Metric BIO S.Median
Beta 0.88 0.84
VaR 20.8 25.23
E.Shortfall 25.76 45.03
Liquidity 190.62K 95.2K

Fundamental

9 Apr 2020

PE: 31.139

Market Cap: 11.7B

Price Over Book: 2.286

Price Over Sales: 5.09

Return On Assets: 5.2%

Return On Equity: 7.3%

Price Over NAV: [Friends Only]

General

CEO: Norman D. Schwartz

Headquarters: Hercules

Employees: 8,250

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. It operates in Europe, Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.